Activation of the Canonical Wnt/β-Catenin Pathway in ATF3-Induced Mammary Tumors
2011

Wnt/β-Catenin Pathway Activation in Mammary Tumors Induced by ATF3

Sample size: 7 publication 10 minutes Evidence: high

Author Information

Author(s): Yan Leqin, Coletta Luis Della, Powell K. Leslie, Shen Jianjun, Thames Howard, Aldaz C. Marcelo, MacLeod Michael C.

Primary Institution: The University of Texas MD Anderson Cancer Center

Hypothesis

The Wnt/β-catenin pathway is activated in mammary tumors induced by the transcription factor ATF3.

Conclusion

The study demonstrates that the Wnt/β-catenin pathway is activated in mammary tumors induced by ATF3, suggesting its role in tumorigenesis.

Supporting Evidence

  • β-catenin is overexpressed and localized to the nuclei of tumor cells in BK5.ATF3 tumors.
  • Downstream targets of the Wnt/β-catenin pathway are up-regulated in ATF3-induced tumors.
  • Wnt ligands are significantly overexpressed in BK5.ATF3 tumors.
  • Knockdown of ATF3 decreases expression of Wnt pathway genes.
  • ATF3 and JUN proteins bind to AP-1 sites upstream of Wnt target genes.

Takeaway

Mice with a specific gene that makes them produce more of a protein called ATF3 develop breast tumors, and this is linked to a pathway that helps cells grow and divide.

Methodology

The study used transgenic mouse models, immunohistochemistry, and quantitative PCR to analyze gene expression and pathway activation.

Limitations

The study primarily focuses on a specific mouse model, which may not fully represent human breast cancer.

Participant Demographics

Female transgenic mice

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0016515

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication